CNBC’s Jim Cramer dissected Tuesday’s market action, speculating about how President Donald Trump’s first days in the White House are…
CNBC's Jim Cramer dissected Tuesday's market action, speculating about how President Donald Trump's first days in the White House are impacting the market.
He suggested that stocks rallied because some investors believe Trump's tariff promises are more severe than his action will be. "In the last go round, Trump did lay into companies that were moving operations to Mexico. He did opine that Amazon abused the Post Office. But those were all buying opportunities," he said."This time, he carried a big stick going into the White House but spoke softly once he was ensconced in 1600 Pennsylvania Avenue."dissected Tuesday's market action, speculating about how President Donald Trump's first days in the White House are impacting the market.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
First Horizon CEO says he's cautious about interest rate cuts in 2025CNBC’s Jim Cramer highlights the regional bank space, talking with First Horizon CEO Bryan Jordan.
Read more »
Jim Cramer's top 10 things to watch in the stock market FridayPresident Joe Biden won't enforce the TikTok ban, and very important price target cuts on Coca-Cola and PepsiCo shares.
Read more »
CNBC Investing Club with Jim Cramer: Bristol Myers Squibb, DuPont Spinoff, and AI Chip DemandJim Cramer highlights Bristol Myers Squibb as a potential top stock for 2025, discussing the company's promising schizophrenia drug and other potential applications. DuPont accelerates its spinoff timeline, while Cramer expresses a preference for selling Honeywell shares. Taiwan Semiconductor Manufacturing's strong AI chip revenue projections benefit Club holdings Nvidia and Broadcom.
Read more »
Jim Cramer Boosts Bristol Myers Squibb Position, Sees Growth PotentialJim Cramer's Charitable Trust increases its stake in Bristol Myers Squibb, citing confidence in the company's growth prospects, particularly with its new schizophrenia treatment, Cobenfy. The Trust also discusses its rationale for maintaining a position in Coterra Energy despite a desire to trim holdings due to trading restrictions.
Read more »
Jim Cramer Impressed by Bank Earnings, Recommends Wells Fargo and Goldman SachsCNBC's Jim Cramer applauds the strong earnings reports from leading banks, emphasizing the growth potential of Wells Fargo and Goldman Sachs. He encourages investors to consider adding bank stocks to their portfolios, highlighting their attractive valuations and future prospects.
Read more »
Jim Cramer Impressed by Bank Earnings, Highlights Wells Fargo and Goldman SachsCNBC's Jim Cramer reviewed earnings reports from top banks this week, praising all of them, particularly Wells Fargo and Goldman Sachs. He believes investors would have benefited from owning these stocks and sees further upside potential due to their strong earnings performance.
Read more »